1 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Phase 3 Study of Obexelimab in Patients With IgG4-Related DiseaseImmunoglobulin G4-Related Disease, autoimmune disease, immune system disorderActive, not recruitingPhase 32026-02-04NCT05662241